CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Highnoon Laboratories Limited Company Snapshot
Highnoon Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Highnoon Laboratories Limited with three other pharmaceutical manufacturers in Asia: Zhejiang Garden Bio-Chemical High-Tech Co Ltd of China (2016 sales of 329.09 million Chinese Renmimbi [US$48.19 million] of which 99% was Food), Choa Pharmaceutical Company Limited of South Korea (55.55 billion Korean Won [US$48.66 million] of which 100% was Pharmaceutical Products), and Korean Drug Co Ltd which is also based in South Korea (55.31 billion Korean Won [US$48.45 million] ).

Sales Analysis. Highnoon Laboratories Limited reported sales of 5.07 billion Pakistan Rupees (US$48.38 million) for the year ending December of 2016. This represents an increase of 15.1% versus 2015, when the company's sales were 4.40 billion Pakistan Rupees. This was the fourth straight year of sales growth at Highnoon Laboratories Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Highnoon Laboratories Limited
  Stock Performance Chart for Highnoon Laboratories Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (6/21/2017): 606.75
(Figures in Pakistan Rupees)
1 Week 2.0%   13 Weeks 2.3%  
4 Weeks 4.5%   52 Weeks 17.7%  
 
Highnoon Laboratories Limited Key Data:
  Ticker: HINOON Country: Pakistan
  Exchanges: KAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 5,070,755,394
(Year Ending Jan 2017).
Employees: 1,065
  Currency: Pakistan Rupees Market Cap: 15,497,800,718
  Fiscal Yr Ends: December Shares Outstanding: 25,542,317
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.